ALTEOGEN INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 286,000 KRW | +1.78% |
|
+6.92% | +190.36% |
| 2023 | Alteogen Inc. Announces Clinical Trial of Tergase Showed Zero Incidence of ADA | CI |
| 2023 | ALTEOGEN Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 10.96B | ||||||
| 93.98B | ||||||
| 37.69B | ||||||
| 32.99B | ||||||
| 28.27B | ||||||
| 16.17B |
- Stock Market
- Equities
- A196170 Stock
- Charts ALTEOGEN Inc.
- Sector Chart
